Lucille joined Abingworth in August 2021, bringing over nine years of healthcare experience spanning venture investing, strategy consulting, clinical practice and academic research. She works with the team in London, Boston and Menlo Park to source and evaluate new investment opportunities and to support existing portfolio companies across a range of therapeutic areas and stages of development.
Prior to joining Abingworth, Lucille worked as a Senior Associate at F-Prime Capital where she was involved in a number of early-stage biotechnology investments. Before F-Prime, Lucille was an engagement manager at McKinsey & Company, focusing on corporate strategy and commercial due diligence for biopharma and private equity clients. Earlier in her career, Lucille served as a physician for five years at The National Hospital for Neurology and Neurosurgery, Imperial College and Barts Healthcare trusts.
Lucille holds degrees in Clinical Neuroscience and in Medicine with distinction from the University of Glasgow. She is a Member of the Royal College of Physicians London.
